pBOB-EF1-FastFUCCI-Puro Citations (9)
Originally described in: Quantitative FastFUCCI assay defines cell cycle dynamics at single-cell level.Koh SB, Mascalchi P, Rodriguez E, Lin Y, Jodrell DI, Richards FM, Lyons SK J Cell Sci. 2016 Nov 25. pii: jcs.195164. PubMed Journal
Articles Citing pBOB-EF1-FastFUCCI-Puro
| Articles |
|---|
| Staufen1 is Essential for Cell-Cycle Transitions and Cell Proliferation Via the Control of E2F1 Expression. Ghram M, Bonnet-Magnaval F, Hotea DI, Doran B, Ly S, DesGroseillers L. J Mol Biol. 2020 Jun 12;432(13):3881-3897. doi: 10.1016/j.jmb.2020.04.016. Epub 2020 Apr 23. PubMed |
| Time-of-day specificity of anticancer drugs may be mediated by circadian regulation of the cell cycle. Lee Y, Fong SY, Shon J, Zhang SL, Brooks R, Lahens NF, Chen D, Dang CV, Field JM, Sehgal A. Sci Adv. 2021 Feb 12;7(7). pii: 7/7/eabd2645. doi: 10.1126/sciadv.abd2645. Print 2021 Feb. PubMed |
The MEMIC is an ex vivo system to model the complexity of the tumor microenvironment.
Janska L, Anandi L, Kirchberger NC, Marinkovic ZS, Schachtner LT, Guzelsoy G, Carmona-Fontaine C.
Dis Model Mech. 2021 Aug 1;14(8). pii: 271783. doi: 10.1242/dmm.048942. Epub 2021 Aug 18.
PubMed
Associated Plasmids |
| Discovery of a potent cytotoxic agent that promotes G2/M phase cell cycle arrest and apoptosis in a malignant human pharyngeal squamous carcinoma cell line. Nuth M, Benakanakere MR, Ricciardi RP. Int J Oncol. 2022 Apr;60(4). pii: 41. doi: 10.3892/ijo.2022.5331. Epub 2022 Feb 25. PubMed |
| Genetic instability from a single S phase after whole-genome duplication. Gemble S, Wardenaar R, Keuper K, Srivastava N, Nano M, Mace AS, Tijhuis AE, Bernhard SV, Spierings DCJ, Simon A, Goundiam O, Hochegger H, Piel M, Foijer F, Storchova Z, Basto R. Nature. 2022 Apr;604(7904):146-151. doi: 10.1038/s41586-022-04578-4. Epub 2022 Mar 30. PubMed |
| Emi2 enables centriole amplification during multiciliated cell differentiation. Kim S, Chien YH, Ryan A, Kintner C. Sci Adv. 2022 Apr;8(13):eabm7538. doi: 10.1126/sciadv.abm7538. Epub 2022 Apr 1. PubMed |
| A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor. Chen H, Diolaiti ME, O'Leary PC, Rojc A, Krogan NJ, Kim M, Ashworth A. Mol Cancer Ther. 2022 Jul 5;21(7):1076-1089. doi: 10.1158/1535-7163.MCT-21-0841. PubMed |
| Endothelial cell cycle state determines propensity for arterial-venous fate. Chavkin NW, Genet G, Poulet M, Jeffery ED, Marziano C, Genet N, Vasavada H, Nelson EA, Acharya BR, Kour A, Aragon J, McDonnell SP, Huba M, Sheynkman GM, Walsh K, Hirschi KK. Nat Commun. 2022 Oct 6;13(1):5891. doi: 10.1038/s41467-022-33324-7. PubMed |
| mTOR inhibition attenuates chemosensitivity through the induction of chemotherapy resistant persisters. Liu Y, Azizian NG, Sullivan DK, Li Y. Nat Commun. 2022 Nov 17;13(1):7047. doi: 10.1038/s41467-022-34890-6. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.